A recent study has found that dronabinol, a synthetic version of THC (the primary psychoactive component in cannabis), ...

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Prolactin is an important hormone in reproduction, pregnancy and childbirth. But could it also play a role in the development ...

Research shows antipsychotic use in people with schizophrenia increases the risk of severe respiratory infections and ...

Christopoulos, Dean of the Faculty of Pharmaceutical Sciences at Monash University, is at the centre of a significant ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

High MMP9 was associated with poor antipsychotic treatment response and changes in white matter density among patients with schizophrenia.

HDL cholesterol levels not linked to risk of developing movement disorders, suggests research published in the Innovations in ...

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...